Settlement Agreement and First Amendment to the License, Manufacture, and Distribution Agreement by and between Nutraceutix, Inc. and SCOLR Pharma, Inc.Settlement Agreement and First Amendment to the License, Manufacture, and Distribution Agreement • August 5th, 2005 • SCOLR Pharma, Inc. • In vitro & in vivo diagnostic substances • Washington
This Settlement Agreement and First Amendment (“Agreement”) is entered into by and between Nutraceutix, Inc., a Washington corporation, (“Nutraceutix”) and SCOLR Pharma, Inc., a Delaware corporation (f/k/a SCOLR, Inc., and referred to herein as “SCOLR”) effective as of the Effective Date set forth below (collectively, Nutraceutix and SCOLR are referred to herein as “Parties”). The purpose of this Agreement is to reflect certain agreements and understandings of the Parties regarding the Asset Purchase Agreement between the Parties, dated December 31, 2003 (“Purchase Agreement”) and other matters described herein and to amend that certain License, Manufacture, and Distribution Agreement, between the Parties dated December 31, 2003 (“Licensing Agreement”).
